Clinico-pathologic Parameters for Prediction of Microsatellite Instability in Colorectal Cancer

Abstract

Bethesda guidelines, tumor location, and negative expression of MLH1 protein are important parameters for selection of patients with colorectal cancers for MSI testing. MSI testing is recommended for patients showing any of these three parameters.